Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Troelsgaard Buchholt, A"'
Autor:
Amanda Hansson-Hedblom, Chrissy Almond, Fredrik Borgström, Indeg Sly, Dana Enkusson, Anders Troelsgaard Buchholt, Linda Karlsson
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 16, Iss 1, Pp 1-12 (2018)
Abstract Background Human monoclonal antibody ustekinumab is a novel Crohn’s disease (CD) treatment blocking pro-inflammatory cytokines interleukin-12 and 23. The study’s objective was to assess cost-effectiveness of ustekinumab in moderate to se
Externí odkaz:
https://doaj.org/article/77378702b6df4fb88d92e17e7b5c6340
Publikováno v:
Current Medical Research and Opinion. 33:1155-1163
This study evaluates the cost of achieving glycemic control with three sodium glucose co-transporter 2 (SGLT2) inhibitors, canagliflozin, dapagliflozin, and empagliflozin, in patients with type 2 diabetes mellitus (T2DM) from the payer perspective in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b5a0d0a6486c1931d70ef50c99b1fa6
https://doi.org/10.1080/03007995.2017.1310091
https://doi.org/10.1080/03007995.2017.1310091
Autor:
Chrissy Almond, Dana Enkusson, Anders Troelsgaard Buchholt, Linda Karlsson, Indeg Sly, A Hansson-Hedblom, Fredrik Borgström
Publikováno v:
Cost Effectiveness and Resource Allocation : C/E
Cost Effectiveness and Resource Allocation, Vol 16, Iss 1, Pp 1-12 (2018)
Cost Effectiveness and Resource Allocation, Vol 16, Iss 1, Pp 1-12 (2018)
Background Human monoclonal antibody ustekinumab is a novel Crohn’s disease (CD) treatment blocking pro-inflammatory cytokines interleukin-12 and 23. The study’s objective was to assess cost-effectiveness of ustekinumab in moderate to severely ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0fdee63d463bfd280425727cc5b0b1f
https://pubmed.ncbi.nlm.nih.gov/30123097
https://pubmed.ncbi.nlm.nih.gov/30123097
Autor:
L Karlsson, C Almond, A Hansson-Hedblom, Dana Enkusson, I Sly, Fredrik Borgström, A Troelsgaard Buchholt
Publikováno v:
Value in Health. 20:A634
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49f81d72941ab145372fcac68e801316
https://doi.org/10.1016/j.jval.2017.08.1435
https://doi.org/10.1016/j.jval.2017.08.1435
Autor:
Hansson-Hedblom, A, Almond, C, Borgström, F, Sly, I, Enkusson, D, Troelsgaard Buchholt, A, Karlsson, L
Publikováno v:
In Value in Health October-November 2017 20(9):A634-A634
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.